Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2007-04-17 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第五届董事会第二十五次会议决议暨召开2006年度股东大会的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 25th meeting of the 5th Board of Directors of Wuhan Mayinglong Pharmaceutical Group Co., Ltd., including approval of various reports, amendments to company bylaws, and nomination of candidates for the 6th Board of Directors. It also announces the convening of the 2006 Annual General Meeting (AGM) with detailed agenda items such as approval of the 2006 annual report, financial statements, profit distribution, and other governance matters. The document includes candidate biographies, independent director declarations, and proxy forms related to the AGM. The content focuses on board and management decisions, governance changes, and preparations for the AGM rather than the full annual report or financial statements themselves. The document length (7155 characters) and detailed meeting resolutions indicate it is not a brief announcement but a substantive board and management information disclosure. Therefore, the most appropriate classification is Board/Management Information (MANG).
2007-04-17 Chinese
第五届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the 15th meeting of the 5th Supervisory Board of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes approval of the company's 2007 first quarter report and other supervisory board matters such as work reports, amendments to meeting rules, and election of new supervisory board members. The document is relatively short (1107 characters) and primarily serves as a meeting resolution announcement rather than containing the full quarterly report or detailed financial data. It does not contain the actual financial statements or substantive financial analysis required for an Interim/Quarterly Report (IR) classification. Instead, it is a regulatory announcement about the supervisory board's approval and related governance matters. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2007-04-17 Chinese
2007年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2007 年第一季度报告' which translates to '2007 First Quarter Report'. It contains detailed financial statements including balance sheet, income statement, and cash flow statement for the quarter ending March 31, 2007. The report includes management's statements on the authenticity of the data, financial metrics, shareholder information, and notes on significant changes and events during the quarter. The document length is over 10,000 characters and contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2007
2007-04-17 Chinese
2006年年度报告
Annual Report Classification · 100% confidence The document is titled "2006 年年度报告" which translates to "2006 Annual Report". It contains detailed financial data, company information, board and management details, shareholder information, and governance structure. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes audited financial statements, management discussion, and comprehensive company disclosures typical of an annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2006
2007-03-23 Chinese
2006年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2006 Annual Report Summary" of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It contains detailed financial data, management discussion and analysis, business overview, accounting policies, shareholder information, and future outlook. The content includes comprehensive financial figures for the year 2006, comparisons with previous years, and detailed narrative on company operations and strategy. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. The document is a summary excerpt of the full annual report, which is typical for an Annual Report (10-K equivalent). Therefore, the document fits the definition of an Annual Report (10-K). FY 2006
2007-03-23 Chinese
第五届董事会第二十四次会议决议公告
Annual Report Classification · 95% confidence The document is a formal announcement of resolutions passed at the 24th meeting of the 5th Board of Directors of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes approval of the 2006 annual financial statements, profit distribution plan, the 2006 annual report text and summary, changes in accounting policies in compliance with new accounting standards, and approval of guarantees for a subsidiary. The document contains detailed financial figures for the 2006 fiscal year and discusses substantive financial and accounting policy matters. It is not merely an announcement of a report publication but includes actual financial data and management decisions. Therefore, it fits the definition of an Annual Report (10-K) type document, which covers the company's yearly activity and full financial performance. FY 2006
2007-03-23 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.